• This event has passed.

How Hormones Can Tell a Fertility Story

June 8, 2022 @ 12:00 pm - 12:45 pm EDT

In the United States, there are more than 100 diagnostic tests and procedures available for detecting diseases and monitoring their progression. Diagnostic tools are also used to guide treatments and evaluate their effectiveness. Some tests are invasive, such as a biopsy or endoscopy; whereas others are noninvasive, such as x-rays and ultrasound imaging procedures.

Innovations in diagnostics provide access to health information, helping women make informed decisions about their health care at every stage of their lives. Screening and diagnostic testing can lead to earlier detection of disease, improve health outcomes, and contribute toward reducing health disparities among women.

SWHR is hosting a series of public forums to share educational information about the importance and value of innovative diagnostics throughout the lifespan and across disease states and conditions. The events discuss how to improve health outcomes for diseases and conditions that disproportionately or exclusively affect women, with special a focus on cancers, reproductive health, and bone health.

The SWHR Value of Diagnostics within Women’s Health series includes:

+ Google Calendar+ Add to iCalendar

Details

Date:
June 8, 2022
Time:
12:00 pm - 12:45 pm EDT
Event Categories:
,
Website:
https://swhr-org.zoom.us/webinar/register/WN_auk-63B1QuG-2b1JMVOVpw

Venue

Virtual Event

Organizer

SWHR

Goals

  • Discuss the impacts of infertility on women’s health, including disparities in disease burden and access to care
  • Provide an overview of tests for evaluating female (and male) infertility (including hormone tests for AMH, FSH, and estradiol, and clomiphene citrate challenge test)and key considerations for treating infertility
  • Increase visibility of the patient experience, emphasizing ways to empower women and improve quality of care and reproductive health

Panelists

Hugh S. Taylor, MD
Chair of Obstetrics, Gynecology and Reproductive Sciences and Professor of Molecular, Cellular and Development Biology, Yale School of Medicine
Hugh S. Taylor, MD
Chair of Obstetrics, Gynecology and Reproductive Sciences and Professor of Molecular, Cellular and Development Biology, Yale School of Medicine

Hugh S. Taylor, MD, is Chair of Obstetrics, Gynecology and Reproductive Sciences and Professor of Molecular, Cellular and Development Biology at Yale School of Medicine, as well as Chief of Obstetrics and Gynecology at Yale New Haven Hospital. Dr. Taylor is internationally known for his studies on endometriosis and has been elected to the National Academy of Medicine, one of the nation’s highest honors in the fields of health and medicine. He is an active researcher and has been funded by the National Institutes of Health continuously for more than 20 years. In 2020, he received the Distinguished Scientist Award from the Society for Reproductive Investigation. Dr. Taylor received his medical degree from the University of Connecticut and completed his residency at Yale-New Haven Hospital, followed by two fellowships at Yale University School of Medicine. Dr. Taylor also currently serves as President of the American Society for Reproductive Medicine.

Regina Townsend
Patient Advocate and Founder, The Broken Brown Egg
Regina Townsend
Patient Advocate and Founder, The Broken Brown Egg

Regina Townsend is an advocate, public speaker, and librarian who uses the intersection of these passions to help others feel seen, heard, and empowered by bringing light to the issues affecting marginalized groups. As the founder and voice behind The Broken Brown Egg, Regina is passionate about bringing light to the struggle of infertility in the African American community. She and her husband spent nearly a decade on their fertility journey – battling hypothyroidism, PCOS, blocked Fallopian tubes, Type 2 diabetes, and some male-factor issues as well. Now, through her advocacy and her health blog, she’s committed to connecting people to the resources they need to make informed health decisions.

Sponsor

SWHR’s Value of Diagnostics within Women’s Health series is supported by an educational sponsorship from Roche. SWHR maintains editorial control and independence over educational content.